Reimbursement Progress for RECELL
Significant progress in reimbursement for RECELL procedures, with all 7 MACs now publishing or confirming acceptance of provider reimbursement rates, leading to renewed demand and expected utilization normalization.
European Expansion
RECELL GO received CE Mark approval in Europe, with the first patient treated in Germany, broadening access and underscoring global relevance.
Cost Management and Reduction
Operating expenses were reduced by 24% year-over-year, with a $7.2 million decrease, reflecting effective cost management and commercial restructuring.
Strong Gross Margin for RECELL
Gross profit margin for the RECELL franchise remained strong at 83.6%, contributing to overall financial health.
Cash Management Improvement
Significant improvement in cash management, with operating cash use reduced by nearly 40% quarter-over-quarter.